Iovance Biotherapeutics Newsroom

H.C. Wainwright Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $32

Futu News00:31

Promising Efficacy and Long-term Response of Iovance Biotherapeutics' Lifileucel in NSCLC: A Buy Recommendation

TipRanks00:27

Barclays Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsNov 5 17:34

Barclays Reaffirms Their Buy Rating on Iovance Biotherapeutics (IOVA)

TipRanksNov 5 17:31

Iovance Biotherapeutics Analyst Ratings

BenzingaOct 24 19:33

UBS Initiates Iovance Biotherapeutics(IOVA.US) With Buy Rating, Announces Target Price $17

Futu NewsOct 24 18:31

Piper Sandler Maintains Iovance Biotherapeutics(IOVA.US) With Hold Rating, Maintains Target Price $10

Futu NewsOct 17 19:31

Stifel Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $23

Futu NewsOct 14 23:31

Stifel Nicolaus Keeps Their Buy Rating on Iovance Biotherapeutics (IOVA)

TipRanksOct 14 23:15

Baird Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $24

Futu NewsSep 13 00:32

TD Cowen Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating

Futu NewsAug 14 20:33

Truist Financial Sticks to Its Buy Rating for Iovance Biotherapeutics (IOVA)

TipRanksAug 12 19:33

Analysts Are Bullish on Top Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Iovance Biotherapeutics (IOVA)

TipRanksAug 12 19:33

Iovance Biotherapeutics Analyst Ratings

BenzingaAug 12 18:25

HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $32 Price Target

BenzingaAug 12 18:25

Iovance Biotherapeutics Poised for Strong Market Position and Financial Growth: Buy Rating Affirmed

TipRanksAug 12 00:57

Iovance Biotherapeutics Analyst Ratings

BenzingaJul 29 17:38

Piper Sandler Downgrades Iovance Biotherapeutics(IOVA.US) to Hold Rating, Cuts Target Price to $10

Futu NewsJul 29 17:33

Barclays Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsJul 29 16:31

Barclays Reaffirms Their Buy Rating on Iovance Biotherapeutics (IOVA)

TipRanksJul 29 16:17